Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale
- PMID: 18441528
- DOI: 10.1159/000128325
Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale
Abstract
Background: Psychosis is present in 50% or more of patients with bipolar mania and is commonly evaluated in clinical research by means of the Positive and Negative Syndrome Scale (PANSS). The aim of the present analysis was to investigate the psychotic dimensions of bipolar disorder and its contributing symptoms based on a factor analysis of baseline PANSS scores and to compare them with those identified in studies of patients with schizophrenia and bipolar disorder.
Sampling and methods: Baseline data were analyzed from two 3-week, double-blind, placebo-controlled studies of risperidone monotherapy for acute mania associated with bipolar I disorder (n = 535). Inclusion criteria were a DSM-IV diagnosis of bipolar I disorder with manic features, with or without psychotic features, age > or =18 years, and mean baseline Young Mania Rating Scale scores > or =20. A principal component analysis of the 30 PANSS item scores of the 535 patients with a diagnosis of a manic episode at baseline was conducted.
Results: Five factors were extracted by the analysis: anxiety (13.4% of the variance), negative symptoms (12.3%), depression (10.5%), excitement (10.3%), and positive symptoms (8.7%). Similar factors, in particular the negative, excitement, and positive factors, have been identified in patients with schizophrenia. There was an absence of a cognitive factor supporting the notion that bipolar patients may present fewer cognitive symptoms.
Conclusion: The results of the present analysis and those of other studies indicate similarities in psychotic symptom domains, as measured by the PANSS, in patients with bipolar mania and schizophrenia. Future analyses will address the effects of treatment on the identified factors.
(c) 2008 S. Karger AG, Basel
Similar articles
-
Psychotic symptoms in patients with bipolar mania.J Affect Disord. 2008 Dec;111(2-3):164-9. doi: 10.1016/j.jad.2008.02.014. Epub 2008 Apr 2. J Affect Disord. 2008. PMID: 18378001 Clinical Trial.
-
Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.J Affect Disord. 2007;100 Suppl 1:S5-14. doi: 10.1016/j.jad.2007.02.007. Epub 2007 Mar 27. J Affect Disord. 2007. PMID: 17391773
-
Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.J Clin Psychiatry. 2001 Oct;62(10):818-25. J Clin Psychiatry. 2001. PMID: 11816872
-
Clozapine in treatment-refractory mood disorders.J Clin Psychiatry. 1994 Sep;55 Suppl B:91-3. J Clin Psychiatry. 1994. PMID: 7961583 Review.
-
[How to differentiate schizophrenia from bipolar disorder using cognitive assessment?].Encephale. 2009 Apr;35(2):139-45. doi: 10.1016/j.encep.2008.03.011. Epub 2008 Sep 23. Encephale. 2009. PMID: 19393382 Review. French.
Cited by
-
Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder: A Prospective Study on the Effects of Time.Clin Psychopharmacol Neurosci. 2022 Aug 31;20(3):482-490. doi: 10.9758/cpn.2022.20.3.482. Clin Psychopharmacol Neurosci. 2022. PMID: 35879032 Free PMC article.
-
Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder.Transl Psychiatry. 2016 Sep 13;6(9):e891. doi: 10.1038/tp.2016.157. Transl Psychiatry. 2016. PMID: 27622935 Free PMC article.
-
Pareidolia in Schizophrenia and Bipolar Disorder.Front Psychiatry. 2021 Dec 10;12:746734. doi: 10.3389/fpsyt.2021.746734. eCollection 2021. Front Psychiatry. 2021. PMID: 34955913 Free PMC article.
-
Association between symptom dimensions and categorical diagnoses of psychosis: a cross-sectional and longitudinal investigation.Schizophr Bull. 2014 Jan;40(1):111-9. doi: 10.1093/schbul/sbt055. Epub 2013 May 9. Schizophr Bull. 2014. PMID: 23661632 Free PMC article.
-
An economic evaluation of a contingency-management intervention for stimulant use among community mental health patients with serious mental illness.Drug Alcohol Depend. 2015 Aug 1;153:293-9. doi: 10.1016/j.drugalcdep.2015.05.004. Epub 2015 May 14. Drug Alcohol Depend. 2015. PMID: 26026494 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical